Search hospitals > New York > Commack
MSK Commack
Claim this profileCommack, New York 11725
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Colorectal Cancer
Conducts research for Cancer
Conducts research for Breast Cancer
5 reported clinical trials
0 medical researchers
Summary
MSK Commack is a medical facility located in Commack, New York. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Colorectal Cancer, Cancer, Breast Cancer and other specialties. MSK Commack is involved with conducting 5 clinical trials across 34 conditions. There are 0 research doctors associated with this hospital, such as .Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
PD-L1 positive
2Lung Cancer
Stage IV
Stage III
PD-L1 positive
Top PIs
Clinical Trials running at MSK Commack
Colorectal Cancer
Multiple Myeloma
Brain Tumor
Bladder Cancer
Melanoma
Thyroid Cancer
Cancer
Lymphoma
Lung Cancer
Non-Small Cell Lung Cancer
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
PF-07799544
for Cancer
This trial tests a new cancer medicine, PF-07799544, taken regularly as a tablet. It is for people with advanced solid tumors who haven't responded to other treatments. The medicine may be used alone or with other drugs to improve its effectiveness.
Recruiting1 award Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at MSK Commack?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.